A Dynamic Relationship between Intracellular and Extracellular Pools of Aβ

Oddo, Salvatore, Caccamo, Antonella, Smith, Ian F., Green, Kim N., LaFerla, Frank M.·2006·The American Journal of Pathology
DOI 10.2353/ajpath.2006.050593

Cited by (261)

Items 201–261 of 261

  1. SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making?
    Nathaniel G.N. Milton · 2023 · Frontiers in Dementia
  2. The age-related slow increase in amyloid pathology in APP.V717I mice activates microglia, but does not alter hippocampal neurogenesis.
    L. Hoeijmakers, G. Meerhoff, Janneke W. de Vries, S. Ruigrok, A. van Dam, F. Van Leuven, A. Korosi, P. Lucassen · 2018 · Neurobiology of Aging
  3. Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure
    Silvia Hilt, Ruiwu Liu, Izumi Maezawa, Tatu Rojalin, Hnin Hnin Aung, Madhu S. Budamagunta, Ryan R. Slez, Qizhi Gong, Randy P. Carney, John C. Voss · 2022 · Frontiers in Chemistry
  4. Intra-cellular accumulation of amyloid is a marker of selective neuronal vulnerability in Alzheimer’s disease
    Alessia Caramello, Nurun Nahar Fancy, Clotilde Tournerie, Maxine Eklund, Vicky M. N. Chau, Emily Adair, Marianna Papageorgopoulou, Johanna Jackson, John Hardy, Paul McMahan Matthews · 2023 · medRxiv
  5. Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change
    Nauman Malik, Mohi-Uddin Miah, Alessandro Galgani, Kirsty E. McAleese, Lauren Walker, Fiona E. N. LeBeau, Johannes Attems, Tiago F. Outeiro, Alan J. Thomas, David J. Koss · 2024 · Acta Neuropathologica
  6. Alzheimer’s Disease and Diabetes
    David A. Brent, Gary L., Zaid Aboud, Gordon W. · 2013 · InTech eBooks
  7. The 3xTg-AD Mouse Model: Reproducing and Modulating Plaque and Tangle Pathology
    Michael Sy, Masashi Kitazawa, Frank M. LaFerla · 2010 · Neuromethods
  8. A drug targeting intracellular amyloid-β and oxidative stress: Apomorphine
    Yasumasa Ohyagi · 2011 · Rinsho Shinkeigaku
  9. Explore peptides extracted from gliadin hydrolysates suppressing BACE1 activity and restraining Aβ protein deposition
    Kuo‐Chiang Hsu, Shang-Ming Huang, Jhih-Yi Shen, Long Yi Chan, Pei-Yu Lai, Chin‐Yu Lin · 2025 · International Journal of Biological Macromolecules
  10. Shuangxia Decoction attenuates sleep disruption in 5×FAD mice through neuroinflammation inhibition: An integrative analysis of transcriptomic and molecular biology investigations
    Jie Wang, Hao Pan, Haiyan Tang, Jingsi Zhang, Tingting Li, Yizhou Liu, Yiwen Huang, Zhimin Fei, Yu Wang · 2025 · Journal of Ethnopharmacology
  11. A transgenic triple scores a home run
    Greg M. Cole · 2006 · Nature Medicine
  12. Photobiomodulation therapy increases neural stem cell pool in aged 3xTg-AD mice
    Kevin J. Johnson, Kathia M. Johnson, Auston C. Grant, Giulio Taglialatela, Maria‐Adelaide Micci · 2025 · PLoS ONE
  13. Origin(s) of Intraneuronal Amyloid
    Michael R. D’Andrea · 2016 · Elsevier eBooks
  14. Alzheimer disease models and human neuropathology: similarities and diVerences
    Charles J. Duyckaerts, Marie‐Claude Potier, Benoı̂t Delatour · 2008
  15. Genetic Deletion of cyclooxygenase-1 ameliorates neuroinflammation and cognitive impairment in 5×FAD mice
    Jie Wang, Hong Ni, Luyao Wei, Hanqing Ding, Zhongzhao Guo, Ying Yu, Jia Luo, Zunji Ke · 2023 · Research Square
  16. Recent progress in the study of intracellular toxicity of amyloid β peptide in Alzheimer's disease
    Yan Zhang, Long‐Chuan Yu · 2007 · Progress in Natural Science Materials International
  17. Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
    Prashant Bharadwaj · 2011 · Australasian Journal of Paramedicine
  18. Glucose facilitates Aβ oligomerization and tau phosphorylation in C. elegans model of Alzheimer’s disease
    Waqar Ahmad · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Antibody-based therapeutics
    Tatsuhiko Tachibana, Takashi Kuwabara · 2019 · Drug Metabolism and Pharmacokinetics
  20. Análise da expressão das proteínas Rab anterior à agregação proteica associada a neurodegeneração
    Thaiany Quevedo Melo · 2012
  21. Antibody Based Therapeutics for Alzheimer's Disease
    Shanta P. Boddapati · 2011
  22. Characterisation of transgenic mouse models of Alzheimer's disease
    Lindsay Graham · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  23. Bone Marrow-Derived Cell Accumulation in the Brain in a Murine Model of Alzheimer’s Disease
    Christine Barr · 2013 · Summit (Simon Fraser University)
  24. A Dynamic Relationship between Intracellular and Extracellular Pools of Aβ
    Kathryn A. McFadden, Clayton A. Wiley · 2007 · Yearbook of Pathology and Laboratory Medicine
  25. LearningDecreasesA*56andTauPathologyand AmelioratesBehavioralDeclinein3xTg-ADMice
    Lauren M. Billings · 2007
  26. CAN ALTERNATIVE OXIDASE (AOX) COMPLEMENT THE DELETERIUS PHENOTYPE OF DROSOPHILA MELANOGASTER MODELS OF ALZHEIMER´S DISEASE? PREPARATORY GENETIC CROSSES
    Katariina Lassila · 2013 · Tampere University Institutional Repository (Tampere University)
  27. Amyloid-beta Causes Autophagy Dysfunction by Inhibiting Protein Prenylation
    Kevan Thomas Smith · 2016 · ERA: Education and Research Archive (University of Alberta)
  28. Amyloid beta: from pre-analytical factors to disease mechanisms
    Jamie Toombs · 2019 · UCL Discovery (University College London)
  29. Functional spreading of hyperexcitability induced by human and synthetic intracellular Aβ oligomers
    Eduardo J. Fernández-Pérez, Braulio Muñoz, Denisse Bascuñán, Christian Peters, Nicolás Riffo-Lepe, María Paz Espinoza, Peter James Morgan, Caroline Filippi, Romain Bourboulou, Urmi Sengupta et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Electroacupuncture Ameliorates Cognitive Impairment and Beta-Amyloid Pathology Via Inhibiting the Activation of NLRP3 Inflammasome in an Alzheimer's Disease Animal
    Hong Ni, Jiaoqi Ren, Xing Li, Jie Wang, Guobin Liu · 2022 · SSRN Electronic Journal
  31. Ablation of cell-specific cholesterol synthesis affects cerebral β-amyloidosis
    L. Spieth · 2023
  32. Post-mortem AT-8 reactive tau species correlate with non-plaque Aβ levels in the frontal cortex of non-AD and AD brains
    Nauman Malik, Mohi-Uddin Miah, Alessandro Galgani, Kirsty E. McAleese, Lauren Walker, Fiona E. N. LeBeau, Johannes Attems, Tiago F. Outeiro, Alan J. Thomas, David J. Koss · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity
    Madhu S. Budamagunta, Hidetoshi Mori, Joshua Silk, Ryan R. Slez, Balázs Bognár, Ulises Ruiz Mendiola, Tamás Kálai, Izumi Maezawa, John C. Voss · 2024 · Antioxidants
  34. TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease
    Kelly Ceyzériat, Aurélien M. Badina, Laurene Abjean, Léa Meyer, Farha Bouteldja, Marta Bałkota, Quentin Amossé, Oriane Prudhomme, Ryan J. Middleton, Guo-Jun Liu et al. · 2025 · Research Square
  35. SUMO-2 activity is inhibited by non-covalent interactions with the Aβ peptide: an exploration of potential pathogenic mechanisms in Alzheimer's disease
    Valeria Ciaffaglione, Giulia Grasso, Valeria Lanza, Michele F. M. Sciacca, Stefania Zimbone, Maria Laura Giuffrida, Claudio Iacobucci, Alessio Di Ianni, Damiano Calcagno, Giuseppe Grasso et al. · 2025 · International Journal of Biological Macromolecules
  36. Unravelling the Molecular Mechanism of HIV-TAT-Tagged β-Amyloid-Induced Neurotoxicity via Lamin Fragmentation
    Md. Selim Hossain, Vijay Sankar Ramasamy, Md. Aminul Haque, Kamarajan Rajagopalan, Il‐Seon Park · 2025 · Applied Biosciences
  37. Additional file 7 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  38. Additional file 6 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  39. Additional file 1 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  40. Additional file 9 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  41. Additional file 13 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  42. Additional file 5 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  43. Additional file 4 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  44. Additional file 8 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  45. Additional file 12 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  46. Additional file 10 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  47. Additional file 3 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  48. Additional file 2 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  49. Additional file 11 of Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice
    Nataraj Jagadeesan, Roules, G. Chuli, Devaraj Venkatapura Chandrashekar, Joshua Yang, Sanjana Kolluru, Rachita K. Sumbria · 2024 · Figshare
  50. Non-viral vasculogenic reprogramming restores cognition and mitigates pathology in Alzheimer’s disease
    Diego Alzate‐Correa, Jonathan P. Stranan, Maria Angelica Rincon‐Benavides, Natalia Areiza Mazo, Luis Fernando Narváez-Pérez, Shara Jaramillo-Garrido, Tracy Nguyen, Roma Patel, William R. Lawrence, Ludmila Diaz‐Starokozheva et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
    Geoffroy O. Laumet · 2010 · theses.fr (ABES)
  52. Etude de la relation structure - toxicité des protéines amyloïdes en interaction avec des membranes modèles
    Ha Phuong Ta · 2011
  53. La protéine prion cellulaire : un relai de neurotoxicité commun aux protéines amyloïdes et aux nanoparticules
    François Boudet-Devaud · 2018 · theses.fr (ABES)
  54. Rôle du peptide amyloïde dans les maladies neurodégénératives
    Maud Combes · 2018 · theses.fr (ABES)
  55. Implication du fragment C99 dans l’avènement des phénotypes pathologiques de la maladie d’Alzheimer
    Alexandre Bourgeois · 2019 · theses.fr (ABES)
  56. Altérations des synapses et des corps cellulaires neuronaux chez les souris APPxPS1-KI et dans la Maladie d'Alzheimer
    Alexandre Androuin · 2018 · theses.fr (ABES)
  57. Etude des mécanismes physiοpathοlοgiques de la maladie d'Alzheimer : appοrt de l'étude des variants du gène SΟRL1
    Romain Castelot · 2024 · theses.fr (ABES)
  58. APP-CTFβ/C99 Oligomers Drive Synaptic Vesicle Tethering through C-Terminal Interactions
    Akshay Kapadia, Elena Cijffers, Stanley Van, Anne‐Sophie Hafner · 2026 · SSRN Electronic Journal
  59. Integrated computational screening and biochemical validation identify natural small molecules targeting Aβ aggregation and dissociation
    Hyewon Lee, Vijay Kumar, Soo Jung Shin, Yunkwon Nam, Sinae Jang, Hyeon soo Kim, Minseok Lee, Gyu Yong Song, Eun‐Kyung Lim, Han–Jung Chae et al. · 2026 · Journal of Pharmacy & Pharmaceutical Sciences
  60. Neurodegenerative Processes as a Result of Infectious Agent Exposure and the Potential for Therapeutic Development
    Ilya Lyagin · 2026 · Moscow University Chemistry Bulletin
  61. Amyloid precursor protein (APP) and copper homeostasis in the human neuroblastoma cell line SH-SY5Y
    Juliane Klein · 2011